James Boyce
Ophthalmology · Garden Grove, CANPI 1457351652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 34.5% of the total. Reporting peaked in 2019 at $593 and has fallen 95.8% since, to $25 in 2021. That places this record below the midpoint for ophthalmology clinicians in CA, where the typical reported total is $1,218.
Across 51 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$318
- Aerie Pharmaceuticals, Inc.$252
- Shire North American Group Inc$105
- Alcon$92
- Novartis$85
- Regeneron Healthcare Solutions, Inc.$30
- plus $41 from 2 others
Across 55 payments — averaging $6761.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kala Pharmaceuticals, Inc.$245K
- Ocular Therapeutix, Inc.$55K
- AbbVie$33K
- Perrigo Company PLC$20K
- Osmotica Pharmaceutical Corp.$12K
- Bausch Health US, LLC$7K
What the payments were for
- Food & beverage$922100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $318 |
| Aerie Pharmaceuticals, Inc. | 20 | $252 |
| Shire North American Group Inc | 5 | $105 |
| Alcon | 4 | $92 |
| Novartis | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Sun Pharmaceutical Industries Inc. | 2 | $24 |
| Topcon Healthcare Solutions, Inc. | 1 | $17 |
How this compares
$922 in reported general payments places this provider in the 40th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in Garden Grove
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.